Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 6;82(7):1283–1289. doi: 10.1054/bjoc.1999.1092

Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients

D Masson 1, M G Denis 1, P Lustenberger 1
PMCID: PMC2374479  PMID: 10755402

Abstract

Based on the important role of CD44 splice variants in colorectal cancer progression and metastasis, we evaluated the use of CD44v6 expression to detect and assess the metastatic potential of colorectal tumour cells circulating in peripheral blood. A nested amplification was designed that allowed to detect 10–100 colon cancer cells. This assay was applied to blood samples from healthy donors. Strong signals were detected in all cases, indicating that it cannot be used to detect colorectal carcinoma cells in whole blood. We then included an enrichment step based on the use of an anti-epithelial cells monoclonal antibody (BerEP4) coupled to magnetic beads. The CD44v6 reverse transcription polymerase chain reaction (RT PCR) assay was performed on cDNA synthesized from blood samples treated with these beads. We analysed 18 samples from 12 patients with a gastrointestinal disease, and 36 samples from ten patients with a colorectal cancer. None of the patients used as negative controls were found to contain epithelial cells in their blood as determined by cytokeratin 19 RT-PCR. By contrast, CD44 transcripts containing exon v6 were detected in nine out of the 18 samples tested (50%). For the colorectal cancer patients, six out of the seven samples (85.7%) that were cytokeratin 19-positive were CD44v6-negative, whereas ten samples out of the 29 not containing epithelial cells were CD44v6-positive (34.5%). This is probably due to the persistence of CD8+ leucocytes in the enriched preparations, as determined by PCR analysis of the CD8 α-chain. We conclude that detection of CD44v6 transcripts using a sensitive nested RT-PCR assay has no potential value to detect and characterize colorectal cancer micrometastases from blood, even following an initial enrichment step. © 2000 Cancer Research Campaign

Keywords: CD44, exon v6, colorectal cancer, micrometastasis, reverse transcription polymerase chain reaction

Full Text

The Full Text of this article is available as a PDF (125.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTLER V. B., COLLER F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954 Jun;139(6):846–852. doi: 10.1097/00000658-195406000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burchill S. A., Bradbury M. F., Pittman K., Southgate J., Smith B., Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995 Feb;71(2):278–281. doi: 10.1038/bjc.1995.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bustin S. A., Dorudi S. Molecular assessment of tumour stage and disease recurrence using PCR-based assays. Mol Med Today. 1998 Sep;4(9):389–396. doi: 10.1016/s1357-4310(98)01324-0. [DOI] [PubMed] [Google Scholar]
  4. Castells A., Boix L., Bessa X., Gargallo L., Piqué J. M. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer. 1998 Nov;78(10):1368–1372. doi: 10.1038/bjc.1998.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denis M. G., Lipart C., Leborgne J., LeHur P. A., Galmiche J. P., Denis M., Ruud E., Truchaud A., Lustenberger P. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer. 1997 Oct 21;74(5):540–544. doi: 10.1002/(sici)1097-0215(19971021)74:5<540::aid-ijc11>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  6. Eltahir E. M., Mallinson D. S., Birnie G. D., Hagan C., George W. D., Purushotham A. D. Putative markers for the detection of breast carcinoma cells in blood. Br J Cancer. 1998 Apr;77(8):1203–1207. doi: 10.1038/bjc.1998.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Finn L., Dougherty G., Finley G., Meisler A., Becich M., Cooper D. L. Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochem Biophys Res Commun. 1994 Apr 29;200(2):1015–1022. doi: 10.1006/bbrc.1994.1551. [DOI] [PubMed] [Google Scholar]
  8. Funaki N. O., Tanaka J., Itami A., Kasamatsu T., Ohshio G., Onodera H., Monden K., Okino T., Imamura M. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA. Life Sci. 1997;60(9):643–652. doi: 10.1016/s0024-3205(96)00700-x. [DOI] [PubMed] [Google Scholar]
  9. Givehchian M., Wörner S., Sträter J., Zöller M., Heuschen U., Heuschen G., Lehnert T., Herfarth C., von Knebel Doeberitz M. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer. Eur J Cancer. 1998 Jun;34(7):1099–1104. doi: 10.1016/s0959-8049(98)00046-x. [DOI] [PubMed] [Google Scholar]
  10. Gorham H., Sugino T., Woodman A. C., Tarin D. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa. J Clin Pathol. 1996 Jun;49(6):482–488. doi: 10.1136/jcp.49.6.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gotley D. C., Fawcett J., Walsh M. D., Reeder J. A., Simmons D. L., Antalis T. M. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer. 1996 Aug;74(3):342–351. doi: 10.1038/bjc.1996.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Günthert U., Hofmann M., Rudy W., Reber S., Zöller M., Haussmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991 Apr 5;65(1):13–24. doi: 10.1016/0092-8674(91)90403-l. [DOI] [PubMed] [Google Scholar]
  13. Heider K. H., Hofmann M., Hors E., van den Berg F., Ponta H., Herrlich P., Pals S. T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol. 1993 Jan;120(1):227–233. doi: 10.1083/jcb.120.1.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Imazeki F., Yokosuka O., Yamaguchi T., Ohto M., Isono K., Omata M. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. Gastroenterology. 1996 Feb;110(2):362–368. doi: 10.1053/gast.1996.v110.pm8566581. [DOI] [PubMed] [Google Scholar]
  15. Khaldoyanidi S., Achtnich M., Hehlmann R., Zöller M. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression. Leuk Res. 1996 Oct;20(10):839–851. doi: 10.1016/s0145-2126(96)00048-3. [DOI] [PubMed] [Google Scholar]
  16. Kim H., Yang X. L., Rosada C., Hamilton S. R., August J. T. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch Biochem Biophys. 1994 May 1;310(2):504–507. doi: 10.1006/abbi.1994.1199. [DOI] [PubMed] [Google Scholar]
  17. Ko Y., Klinz M., Totzke G., Gouni-Berthold I., Sachinidis A., Vetter H. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin Cancer Res. 1998 Sep;4(9):2141–2146. [PubMed] [Google Scholar]
  18. Koopman G., Heider K. H., Horst E., Adolf G. R., van den Berg F., Ponta H., Herrlich P., Pals S. T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med. 1993 Apr 1;177(4):897–904. doi: 10.1084/jem.177.4.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kryworuckho M., Diaz-Mitoma F., Kumar A. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells. Immunology. 1995 Sep;86(1):41–48. [PMC free article] [PubMed] [Google Scholar]
  20. Latza U., Niedobitek G., Schwarting R., Nekarda H., Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol. 1990 Mar;43(3):213–219. doi: 10.1136/jcp.43.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Le Maire V., Sales J. P., Wind P., Dumas F., Landi B., Fayemendy L., Cugnenc P. H., Gayral F., Lacour B., Loric S. Evaluation et intérêt de nouveaux marqueurs moléculaires en cancérologie colique. Ann Pharm Fr. 1998;56(1):9–17. [PubMed] [Google Scholar]
  22. Levesque M. C., Haynes B. F. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol. 1996 Feb 15;156(4):1557–1565. [PubMed] [Google Scholar]
  23. Littman D. R., Thomas Y., Maddon P. J., Chess L., Axel R. The isolation and sequence of the gene encoding T8: a molecule defining functional classes of T lymphocytes. Cell. 1985 Feb;40(2):237–246. doi: 10.1016/0092-8674(85)90138-2. [DOI] [PubMed] [Google Scholar]
  24. Momburg F., Moldenhauer G., Hämmerling G. J., Möller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res. 1987 Jun 1;47(11):2883–2891. [PubMed] [Google Scholar]
  25. Mulder J. W., Kruyt P. M., Sewnath M., Oosting J., Seldenrijk C. A., Weidema W. F., Offerhaus G. J., Pals S. T. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet. 1994 Nov 26;344(8935):1470–1472. doi: 10.1016/s0140-6736(94)90290-9. [DOI] [PubMed] [Google Scholar]
  26. Mulder J. W., Wielenga V. J., Polak M. M., van den Berg F. M., Adolf G. R., Herrlich P., Pals S. T., Offerhaus G. J. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut. 1995 Jan;36(1):76–80. doi: 10.1136/gut.36.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nakayama K., Tokito S., Okumura K., Nakauchi H. Structure and expression of the gene encoding CD8 alpha chain (Leu-2/T8). Immunogenetics. 1989;30(5):393–397. doi: 10.1007/BF02425282. [DOI] [PubMed] [Google Scholar]
  28. Naor D., Sionov R. V., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71:241–319. doi: 10.1016/s0065-230x(08)60101-3. [DOI] [PubMed] [Google Scholar]
  29. Normanno N., De Luca A., Castaldo A., Casamassimi A., Di Popolo A., Zarrilli R., Porcellini A., Acquaviva A. M., Avvedimento V. E., Pignata S. Apolipoprotein A-I reverse transcriptase-polymerase chain reaction analysis for detection of hematogenous colon cancer dissemination. Int J Oncol. 1998 Sep;13(3):443–447. doi: 10.3892/ijo.13.3.443. [DOI] [PubMed] [Google Scholar]
  30. Orzechowski H. D., Beckenbach C., Herbst H., Stölzel U., Riecken E. O., Stallmach A. Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells. Eur J Cancer. 1995 Nov;31A(12):2073–2079. doi: 10.1016/0959-8049(95)00452-1. [DOI] [PubMed] [Google Scholar]
  31. Pelkey T. J., Frierson H. F., Jr, Bruns D. E. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem. 1996 Sep;42(9):1369–1381. [PubMed] [Google Scholar]
  32. Raj G. V., Moreno J. G., Gomella L. G. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer. 1998 Apr 15;82(8):1419–1442. doi: 10.1002/(sici)1097-0142(19980415)82:8<1419::aid-cncr1>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  33. Ropponen K. M., Eskelinen M. J., Lipponen P. K., Alhava E., Kosma V. M. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol. 1998 Mar;33(3):301–309. doi: 10.1080/00365529850170900. [DOI] [PubMed] [Google Scholar]
  34. Screaton G. R., Bell M. V., Bell J. I., Jackson D. G. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem. 1993 Jun 15;268(17):12235–12238. [PubMed] [Google Scholar]
  35. Screaton G. R., Bell M. V., Jackson D. G., Cornelis F. B., Gerth U., Bell J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12160–12164. doi: 10.1073/pnas.89.24.12160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Verkaik N. S., Schröder F. H., Romijn J. C. Clinical usefulness of RT-PCR detection of hematogenous prostate cancer spread. Urol Res. 1997;25(6):373–384. doi: 10.1007/BF01268851. [DOI] [PubMed] [Google Scholar]
  37. Vogelstein B., Kinzler K. W. The multistep nature of cancer. Trends Genet. 1993 Apr;9(4):138–141. doi: 10.1016/0168-9525(93)90209-z. [DOI] [PubMed] [Google Scholar]
  38. Weitz J., Kienle P., Lacroix J., Willeke F., Benner A., Lehnert T., Herfarth C., von Knebel Doeberitz M. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res. 1998 Feb;4(2):343–348. [PubMed] [Google Scholar]
  39. Wielenga V. J., Heider K. H., Offerhaus G. J., Adolf G. R., van den Berg F. M., Ponta H., Herrlich P., Pals S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 1993 Oct 15;53(20):4754–4756. [PubMed] [Google Scholar]
  40. Wielenga V. J., van der Voort R., Mulder J. W., Kruyt P. M., Weidema W. F., Oosting J., Seldenrijk C. A., van Krimpen C., Offerhaus G. J., Pals S. T. CD44 splice variants as prognostic markers in colorectal cancer. Scand J Gastroenterol. 1998 Jan;33(1):82–87. doi: 10.1080/00365529850166257. [DOI] [PubMed] [Google Scholar]
  41. Wittig B., Seiter S., Schmidt D. S., Zuber M., Neurath M., Zöller M. CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases. Lab Invest. 1999 Jun;79(6):747–759. [PubMed] [Google Scholar]
  42. Wong L. S., Cantrill J. E., Morris A. G., Fraser I. A. Expression of CD44 splice variants in colorectal cancer. Br J Surg. 1997 Mar;84(3):363–367. [PubMed] [Google Scholar]
  43. Wyld D. K., Selby P., Perren T. J., Jonas S. K., Allen-Mersh T. G., Wheeldon J., Burchill S. A. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer. 1998 Jun 19;79(3):288–293. doi: 10.1002/(sici)1097-0215(19980619)79:3<288::aid-ijc14>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  44. van Weering D. H., Baas P. D., Bos J. L. A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl. 1993 Oct;3(2):100–106. doi: 10.1101/gr.3.2.100. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES